Cantor Fitzgerald Boosts Leidos (NYSE:LDOS) Price Target to $225.00

Leidos (NYSE:LDOS) had its price objective increased by analysts at Cantor Fitzgerald from $185.00 to $225.00 in a report issued on Friday, Marketbeat.com reports. The brokerage presently has an “overweight” rating on the aerospace company’s stock. Cantor Fitzgerald’s target price suggests a potential upside of 18.08% from the company’s current price. Cantor Fitzgerald also issued estimates for Leidos’ FY2026 earnings at $11.85 EPS.

A number of other research analysts have also issued reports on LDOS. Argus boosted their target price on Leidos from $185.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 24th. Royal Bank Of Canada raised Leidos from a “hold” rating to a “moderate buy” rating in a report on Thursday, September 4th. Wall Street Zen lowered Leidos from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 9th. Truist Financial set a $195.00 target price on Leidos in a report on Tuesday, September 30th. Finally, Zacks Research downgraded Leidos from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 23rd. Ten research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, Leidos currently has an average rating of “Moderate Buy” and an average target price of $191.38.

Leidos Trading Down 0.2%

LDOS opened at $190.54 on Friday. The firm has a market cap of $24.45 billion, a price-to-earnings ratio of 18.01, a price-to-earnings-growth ratio of 1.79 and a beta of 0.71. Leidos has a 52 week low of $123.62 and a 52 week high of $202.90. The business’s 50 day moving average is $186.51 and its two-hundred day moving average is $167.53. The company has a quick ratio of 1.50, a current ratio of 1.62 and a debt-to-equity ratio of 1.06.

Leidos (NYSE:LDOS) last released its quarterly earnings results on Tuesday, August 5th. The aerospace company reported $3.21 EPS for the quarter, topping the consensus estimate of $2.63 by $0.58. The company had revenue of $4.25 billion for the quarter, compared to analyst estimates of $4.24 billion. Leidos had a return on equity of 33.57% and a net margin of 8.22%.The firm’s revenue was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.63 earnings per share. Leidos has set its FY 2025 guidance at 11.150-11.450 EPS. On average, research analysts predict that Leidos will post 10.62 EPS for the current year.

Insider Buying and Selling

In related news, Director Gregory R. Dahlberg sold 952 shares of the company’s stock in a transaction on Monday, August 11th. The stock was sold at an average price of $177.43, for a total transaction of $168,913.36. Following the transaction, the director owned 21,068 shares of the company’s stock, valued at $3,738,095.24. This represents a 4.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Stephen Edward Hull sold 12,497 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $178.14, for a total value of $2,226,215.58. Following the transaction, the insider directly owned 25,817 shares in the company, valued at $4,599,040.38. This represents a 32.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 22,975 shares of company stock valued at $4,078,740 over the last quarter. Company insiders own 0.96% of the company’s stock.

Institutional Trading of Leidos

A number of institutional investors have recently bought and sold shares of the company. Kathmere Capital Management LLC lifted its position in shares of Leidos by 145.6% in the second quarter. Kathmere Capital Management LLC now owns 7,998 shares of the aerospace company’s stock valued at $1,262,000 after acquiring an additional 4,742 shares in the last quarter. Kendall Capital Management lifted its position in shares of Leidos by 93.7% in the second quarter. Kendall Capital Management now owns 4,270 shares of the aerospace company’s stock valued at $674,000 after acquiring an additional 2,065 shares in the last quarter. McAdam LLC purchased a new stake in shares of Leidos in the second quarter valued at $286,000. Amundi lifted its position in shares of Leidos by 19.1% in the first quarter. Amundi now owns 88,927 shares of the aerospace company’s stock valued at $12,404,000 after acquiring an additional 14,246 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in shares of Leidos by 26.2% in the first quarter. Geneos Wealth Management Inc. now owns 10,229 shares of the aerospace company’s stock valued at $1,380,000 after acquiring an additional 2,126 shares in the last quarter. 76.12% of the stock is currently owned by hedge funds and other institutional investors.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.